Hiroshi Fukuhara Selected Research

CS 834

12/2003	In situ observation of the four-step dehydration process of the 1 beta-methylcarbapenem antibiotic CS-834 crystal by X-rays.
12/2002	Physicochemical analyses of phase transition and dehydration processes of a new oral 1beta-methylcarbapenem antibiotic agent, CS-834.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Fukuhara Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 07/2002
29	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 09/2005
12	Carcinoma (Carcinomatosis) 01/2022 - 03/2012
11	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2007
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2014
4	Overactive Urinary Bladder (Overactive Bladder) 06/2022 - 04/2015
4	Adenocarcinoma 01/2021 - 11/2005
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019 - 09/2015
3	Dehydration (Water Stress) 10/2022 - 12/2002
3	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2022 - 01/2020
3	Stomach Neoplasms (Stomach Cancer) 11/2021 - 02/2021
3	Melanoma (Melanoma, Malignant) 03/2019 - 10/2016
2	Hydronephrosis 01/2022 - 10/2017
2	Sepsis (Septicemia) 03/2020 - 03/2014
2	Hypotension (Low Blood Pressure) 07/2019 - 01/2017
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2018 - 05/2017
2	Infections 12/2016 - 07/2013
2	Lymphatic Metastasis 02/2016 - 09/2012
2	Margins of Excision 01/2014 - 01/2012
2	Lung Neoplasms (Lung Cancer) 09/2002 - 07/2002
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2022
1	Hyperglycemia 06/2022
1	Testicular Neoplasms (Testicular Cancer) 04/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2022
1	Hematuria 01/2022
1	Prolapse 01/2022
1	Pelvic Organ Prolapse 01/2022
1	Disease Progression 01/2022
1	Cysts 05/2021
1	Acute Kidney Injury (Acute Renal Failure) 09/2020
1	Glaucoma 04/2020
1	Pyelonephritis 03/2020
1	Sarcoma (Soft Tissue Sarcoma) 03/2020
1	Stress Urinary Incontinence 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020

Drug/Important Bio-Agent (IBA)

8	AndrogensIBA 05/2018 - 09/2005
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
5	Docetaxel (Taxotere)FDA Link 01/2021 - 12/2011
4	AlbuminsIBA 01/2021 - 02/2016
4	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 09/2013
3	mirabegronIBA 06/2022 - 10/2015
3	Tolvaptan FDA Link 02/2022 - 01/2020
3	talimogene laherparepvecIBA 03/2019 - 10/2016
3	C-Reactive ProteinIBA 09/2017 - 05/2011
2	enzalutamideIBA 03/2022 - 02/2022
2	pembrolizumabIBA 01/2022 - 01/2021
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021 - 06/2021
2	CytokinesIBA 02/2021 - 01/2018
2	GlobulinsIBA 01/2021 - 08/2020
2	naftopidilIBA 01/2020 - 12/2013
2	Muscarinic AntagonistsIBA 01/2019 - 05/2017
2	silodosin FDA Link 01/2018 - 05/2017
2	imidafenacinIBA 05/2017 - 04/2015
2	Alkaline PhosphataseIBA 01/2017 - 05/2011
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2002
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 02/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2016 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 11/2014 - 01/2014
2	Hormones (Hormone)IBA 01/2014 - 09/2005
2	Interleukin-2 (IL2)IBA 07/2007 - 06/2006
2	1 beta-methylcarbapenemIBA 12/2003 - 12/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2003 - 12/2002
2	CS 834IBA 12/2003 - 12/2002
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2002 - 07/2002
2	Immunoglobulins (Immunoglobulin)IBA 09/2002 - 07/2002
1	ReninIBA 10/2022
1	N 30IBA 01/2022
1	AntibodiesIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	NivolumabIBA 01/2022
1	EnzymesIBA 06/2021
1	Melanins (Melanin)IBA 05/2021
1	SynaptophysinIBA 01/2021
1	Chromogranin AIBA 01/2021
1	cabazitaxel FDA Link 01/2021
1	TEMPOIBA 09/2020
1	ProcalcitoninIBA 03/2020
1	Serum AlbuminIBA 03/2020
1	ChromatinIBA 03/2020
1	Selegiline (E250)FDA LinkGeneric 03/2020

Therapy/Procedure

22	Therapeutics 01/2020 - 09/2005
20	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2014
10	Oncolytic Virotherapy 11/2021 - 11/2005
9	Drug Therapy (Chemotherapy) 01/2021 - 12/2011
7	Cystectomy 01/2022 - 01/2015
6	Radiotherapy 09/2020 - 09/2014
4	Castration 03/2022 - 03/2015
4	Nephroureterectomy 01/2022 - 01/2015
3	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2012
3	Transurethral Resection of Bladder 01/2022 - 01/2021
3	Nephrectomy 01/2017 - 06/2012
3	Immunotherapy 01/2017 - 07/2007
2	Intravesical Administration 01/2020 - 11/2016
2	Neoadjuvant Therapy 02/2018 - 04/2015
2	Adjuvant Chemotherapy 10/2017 - 04/2015
2	Orchiectomy (Orchidectomy) 11/2016 - 01/2012
1	Pessaries 01/2022
1	Brachytherapy 09/2020